Drug Discovery 2012

Drug Discovery 2012 More Info

Overview
Gallery
Post Event Review
Overview
ELRIG (European Laboratory and Robotics Interest Group) and SLAS the (Society for Laboratory Automation and Screening) are now preparing for the Sixth Annual Drug Discovery Conference to be held at Manchester Central on 5th & 6th September 2012.

As in previous years the objective of this conference is to provide a communication, education and networking opportunity for scientists engaged in early-phase drug discovery whether in academia, biotech or industry.  As with our highly successful meeting in 2011, attendees will hear world class speakers discussing the challenges and opportunities facing the drug discovery scientist.  The scientific sessions will be complemented by a large poster session, a growing vendor exhibition with over 100 exhibitors including the Innovation Zone, a Media Area, Careers Zone and a number of training sessions.   This year we are featuring a Lunchtime Session sponsored by SLAS – Informatics: Making Knowledge from Laboratory Data

In 2012 the Drug Discovery Symposium will encompass eight Scientific Sessions.

1. Assay Development and Screening
2. Fragment Discovery for Enzyme & Membrane Targets
3. Primary Cells & Stem Cells in Discovery
4. Ubiquitinase Drug Discovery
5. Advances in Liquid Handling & Detection Technologies
6. Compound Collection Management & Enhancement
7. Epigenetic Drug Discovery
8. Biophysics & Label Free Detection Technologies
Gallery
Post Event Review

Related Downloads

Assay Development & Screening

Power to the People! Using crowd sourcing to enhance research (PDF 6.5mb)

Justin Bryans, MRCT
Drug Discovery 2012
2.30 – 3.00 Wednesday 5th September 2012

Fragment Discovery for Enzyme & Membrane Targets

Current Perspectives in Fragment Based Drug Discovery (1mb)

Rod Hubbard, Vernalis
Drug Discovery 2012
9.15 – 10.00 Wednesday 5th September 2012

Primary Cells & Stem Cells in Discovery

Chemical screenings using Stem-cell based technologies (PDF 11.1mb)

Davide Danovi, University College London
Drug Discovery 2012
2.30 – 3.00 Wednesday 5th September 2012

Ubiquitin Cascade Biology & Drug Discovery

Dysfunction of ubiquitin receptors and ubiquitin-mediated processes in human disease (PDF 2mb)

Rob Layfield, Nottingham University
Drug Discovery 2012
11.30 – 12.00 Wednesday 5th September 2012

The Small Ubiquitin-like Modifiers: Established and emerging roles in diseases (PPTX 12.5mb)

Mike Tatham, Dundee University
Drug Discovery 2012
3.30 – 4.00 Wednesday 5th September 2012

Advances in Liquid Handling & Detection Technologies

Advances in High Content Analysis: Phenotypic Drug Discovery (PDF 5.1mb)

Bev Isherwood, AstraZeneca
Drug Discovery 2012
10.00 – 10.30 Thursday 6th September 2012

Simplification of Lead Discovery Using Label Free Detection Technologie (1.3mb)

Melanie Leveridge, GSK
Drug Discovery 2012
2.15 – 2.45 Thursday 6th September 2012

Compound Collection Management & Enhancement

Current Thinking in Compound Collection Enhancement (PDF 1.8mb)

Steffen Renner, Novartis
Drug Discovery 2012
9.15 – 10.00 Thursday 6th September 2012

Current Thinking in Ensuring the Quality of Compound Collections (PDF 4.2mb)

Zoe Blaxill, GSK
Drug Discovery 2012
2.45 – 3.15 Thursday 6th September 2012

Epigentic Drug Discovery

Bromodomains: A new class of epigenetic targets ripe for small molecule drug discovery (PPTX 15.6mb)

Jason Witherington, EpiNova DPU
Drug Discovery 2012
11.00 – 11.30 Thursday 6th September 2012

The Challenges in Turning Epigenetic Hope into Clinical Reality (PDF 17.1mb)

Nessa Carey, Pfizer
Drug Discovery 2012
9.15 – 10.00 Thursday 6th September 2012

Biophysics & Label Free Detection Technologies

Real-time protein interaction assays on living cells (PDF 1.6mb)

Karl Andersson, Sweden University
Drug Discovery 2012
11.00 – 11.30 Thursday 6th September 2012

Background technology and its application to drug discovery (PPTX 5.1mb)

Barrie Martin, Conformetrix Ltd
Drug Discovery 2012
1.45 – 2.15 Thursday 6th September 2012